JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishikawa, K.
Right arrow Articles by Numata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishikawa, K.
Right arrow Articles by Numata, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 3, 589-598, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


FURTHER STUDIES ON THE URINARY METABOLITES OF THIAMINE PROPYL DISULFIDE IN RATS

Kohei Nishikawa 1, Suzuoki-Ziro 1, and Mitsuo Numata 1

1 Biological Research Laboratories and Chemical Research Laboratories, Research and Development Division, Takeda Chemical Industries, Ltd., Osaka, Japan

Of the radioactivity excreted in the urine of rats fed thiamine propyl disulfide-S35 (outer), about 40% was found in the acidic fractions and identified as methylsulfonyl propionic acid and inorganic sulfate after chromatographic separations. The identification of methylsulfonyl propionic acid was accomplished by infrared, nuclear magnetic resonance and mass spectrometry as well as isotope dilution with authentic samples of the acid and its methyl ester. The present metabolites, together with the already characterized ones, methyl propyl sulfone and 2- and 3-hydroxypropyl methyl sulfone, accounted for more than 90% of the urinary radioactivity. A standardized method was established for determination of these metabolites under various dosage regimens. The S-propyl moiety of thiamine propyl disulfide was rapidly and almost quantitatively excreted in the urine after conversion to the methylsulfonyl compounds or sulfate. Among these metabolites, 2-hydroxypropyl methyl sulfone, methylsulfonyl propionic acid and sulfate were the major products. The fate of S35-labeled methyl propyl sulfone, 2- and 3-hydroxypropyl methyl sulfone were also studied. Radioactive inorganic sulfate was not produced from these compounds. All of these results demonstrated the occurrence of two distinct metabolic pathways responsible for the formations of inorganic sulfate and the methylsulfonyl compounds, respectively. The implications of the new pathway involving 5-methylation and sulfoxidation are discussed in connection with the biotransformation of foreign alkyl mercaptans.

Submitted on November 18, 1966
Accepted on May 12, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.